Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4',5,6,7,8-pentamethoxy-flavone
2. 4',5,6,7,8-pentamethoxyflavone
3. Tangeritin
1. 481-53-8
2. Tangeritin
3. Ponkanetin
4. Pentamethoxyflavone
5. 4',5,6,7,8-pentamethoxyflavone
6. 5,6,7,8,4'-pentamethoxyflavone
7. 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)chromen-4-one
8. 4h-1-benzopyran-4-one, 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-
9. 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4h-chromen-4-one
10. Nsc 53909
11. 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4-benzopyrone
12. Nsc53909
13. Nsc-53909
14. I4tla1dlx6
15. Flavone, 4',5,6,7,8-pentamethoxy-
16. Chembl73930
17. Mls002667634
18. Chebi:9400
19. 4h-1-benzopyran-4-one, 5,6,7,8-tetramethoxy-2-(p-methoxyphenyl)-
20. 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4h-1-benzopyran-4-one
21. Nsc618905
22. Flavone, 5,6,7,8,4'-pentamethoxy
23. Nsc-618905
24. Tangeritin; Nsc53909; Nsc618905
25. Tangeretin (6ci)
26. Einecs 207-570-1
27. Unii-i4tla1dlx6
28. Brn 0351695
29. Ai3-23869
30. 4',5,6,7,8-pentamethoxy-flavone
31. Mfcd00017438
32. Tangeretin;tangeratin
33. Tangeretin (tangeritin)
34. 2-(4-methoxyphenyl)-5,6,7,8-tetramethoxy-4h-1-benzopyran-4-one
35. Spectrum2_001698
36. Spectrum3_000920
37. Spectrum4_001019
38. Tangeritin [inci]
39. Tangeretin [who-dd]
40. Schembl19740
41. Kbiogr_001517
42. 5-18-05-00491 (beilstein Handbook Reference)
43. Flavone, 4',5,6,7,8-pentamethoxy- (7ci,8ci)
44. Spectrum1505269
45. Spbio_001656
46. Tangeretin, Analytical Standard
47. Megxp0_001011
48. Tangeretin, >=95% (hplc)
49. Acon1_001263
50. Kbio3_001900
51. Dtxsid30197417
52. Flavone,5,6,7,8-pentamethoxy-
53. Hms3651a22
54. Hy-n0133
55. Zinc1531699
56. 4'',5,6,7,8-pentamethoxyflavone
57. 4h-1-benzopyran-4-one, 2-(4-methoxyphenyl)-5,6,7,8-tetramethoxy-
58. 5,6,7,8,4''-pentamethoxyflavone
59. Bdbm50209218
60. Ccg-38782
61. Lmpk12111443
62. S2363
63. Akos015895209
64. Ac-1699
65. Cs-5484
66. Nsc 618905
67. Sdccgmls-0066766.p001
68. Ncgc00095850-01
69. Ncgc00095850-02
70. Ncgc00169520-01
71. As-11637
72. Nci60_004330
73. Smr001557394
74. Ft-0632194
75. N2077
76. Sw219232-1
77. T2708
78. 481t538
79. A827490
80. Sr-05000002625
81. Cu-01000013437-2
82. Q-100525
83. Q1748737
84. Sr-05000002625-1
85. Brd-k25186396-001-02-1
86. Brd-k25186396-001-04-7
87. 4h-1-benzopyran-4-one,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-
88. 4h-1-benzopyran-4-one,6,7,8-tetramethoxy-2-(p-methoxyphenyl)-
89. 4h-1-benzopyran-4-one, 5,6,7,8-tetra-methoxy-2-(4-methoxyphenyl)-
90. 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4h-1-benzopyran-4-one, 9ci
| Molecular Weight | 372.4 g/mol |
|---|---|
| Molecular Formula | C20H20O7 |
| XLogP3 | 3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 6 |
| Exact Mass | 372.12090297 g/mol |
| Monoisotopic Mass | 372.12090297 g/mol |
| Topological Polar Surface Area | 72.4 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 540 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Tangeretin has known human metabolites that include 4'-Hydroxy-5,6,7,8-tetramethoxyflavone and 5,6-Dihydroxy-7,8,4'-trimethoxyflavone.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
ABOUT THIS PAGE
A Tangeretin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tangeretin, including repackagers and relabelers. The FDA regulates Tangeretin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tangeretin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tangeretin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tangeretin supplier is an individual or a company that provides Tangeretin active pharmaceutical ingredient (API) or Tangeretin finished formulations upon request. The Tangeretin suppliers may include Tangeretin API manufacturers, exporters, distributors and traders.
click here to find a list of Tangeretin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Tangeretin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tangeretin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tangeretin GMP manufacturer or Tangeretin GMP API supplier for your needs.
A Tangeretin CoA (Certificate of Analysis) is a formal document that attests to Tangeretin's compliance with Tangeretin specifications and serves as a tool for batch-level quality control.
Tangeretin CoA mostly includes findings from lab analyses of a specific batch. For each Tangeretin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tangeretin may be tested according to a variety of international standards, such as European Pharmacopoeia (Tangeretin EP), Tangeretin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tangeretin USP).
LOOKING FOR A SUPPLIER?
